Insider holders · CIK 0001113148
INFINITY PHARMACEUTICALS, INC. · INFI
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| BVF Partners OS Ltd.relationship not stated | 1,254,993 | — | 1,254,993 | Dec 17, 2018 · 7:40 pm EST | Form 4 |
| Biotechnology Value Trading Fund OS LPrelationship not stated | 1,254,993 | — | 1,254,993 | Dec 17, 2018 · 7:40 pm EST | Form 4 |
| Mark N Lampert10% Owner | 1,254,993 | — | 1,254,993 | Dec 17, 2018 · 7:40 pm EST | Form 4 |
| BIOTECHNOLOGY VALUE FUND II LP10% Owner | 1,254,993 | — | 1,254,993 | Dec 17, 2018 · 7:40 pm EST | Form 4 |
| Inc/il Bvf10% Owner | 1,254,993 | — | 1,254,993 | Dec 17, 2018 · 7:40 pm EST | Form 4 |
| BVF PARTNERS L P/IL10% Owner | 1,254,993 | — | 1,254,993 | Dec 17, 2018 · 7:40 pm EST | Form 4 |
| BIOTECHNOLOGY VALUE FUND L P10% Owner | 1,254,993 | — | 1,254,993 | Dec 17, 2018 · 7:40 pm EST | Form 4 |
| Lawrence E BlochPresident | 626,133 | 8,959 | 635,092 | Jan 4, 2018 · 4:05 pm EST | Form 4 |
| Adelene Q PerkinsChief Executive Officer | 609,561 | 16,447 | 626,008 | Oct 2, 2018 · 4:30 pm EDT | Form 4 |
| Julian AdamsPresident of R&D | 59,150 | 262,945 | 322,095 | Nov 2, 2016 · 4:56 pm EDT | Form 4 |
| Anthony B EvninDirector | 130,013 | — | 130,013 | Jun 14, 2018 · 8:33 am EDT | Form 4 |
| Eric S LanderDirector | 80,319 | 11,051 | 91,370 | Jun 21, 2016 · 5:53 pm EDT | Form 4 |
| Jeffrey BerkowitzDirector | 58,988 | — | 58,988 | Jun 14, 2018 · 8:35 am EDT | Form 4 |
| Michael C VenutiDirector | 50,000 | — | 50,000 | Mar 20, 2017 · 4:10 pm EDT | Form 4 |
| Seth A TaskerGeneral Counsel | 41,284 | 6,756 | 48,040 | Jan 4, 2018 · 4:07 pm EST | Form 4 |
| Ian F SmithDirector | 45,845 | — | 45,845 | Jun 14, 2018 · 8:34 am EDT | Form 4 |
| Jeffery KutokChief Scientific Officer | 0 | 9,542 | 9,542 | Aug 17, 2018 · 4:05 pm EDT | Form 4 |
| Vito J. PalombellaChief Scientific Officer | 868 | 6,741 | 7,609 | Jun 16, 2015 · 4:15 pm EDT | Form 4 |
| William C Bertrand Jr.General Counsel | 7,500 | — | 7,500 | Oct 21, 2015 · 4:15 pm EDT | Form 3 |
| David W BeierDirector | 5,714 | — | 5,714 | Jun 14, 2018 · 8:30 am EDT | Form 4 |
| Sujay KangoChief Commercial Officer | 599 | 3,598 | 4,197 | Dec 14, 2016 · 5:16 pm EST | Form 4 |
| Christopher M LindblomPrincipal Accounting Officer | 0 | — | 0 | May 4, 2016 · 4:20 pm EDT | Form 3 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.